Related Experiment Video
Updated: Jul 13, 2026
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
Retinoblastoma: from the two-hit hypothesis to targeted chemotherapy
David MacPherson1, Michael A Dyer
1Department of Embryology, Carnegie Institution, Baltimore, Maryland, USA. macpherson@ciwemb.edu
Abstract:
Studies on retinoblastoma have been at the heart of many of the landmark discoveries in cancer genetics over the past 35 years. However, these advances in the laboratory have had little effect on the treatment of children with retinoblastoma. One of the reasons for this has been the lack of preclinical models that recapitulated the genetic and histopathologic features of human retinoblastoma. In the past three years, a series of new animal models of retinoblastoma has been developed and characterized from several different laboratories using a variety of experimental approaches. It is encouraging that there is broad agreement about the consequences of inactivation of the Rb family in retinal development from these studies. More importantly, these new mouse models of retinoblastoma have contributed to clinical trials and novel therapeutic approaches for treating this debilitating childhood cancer.
Insights
New animal models for retinoblastoma, a childhood cancer, now better mimic human disease. These models are crucial for developing effective treatments and advancing clinical trials for retinoblastoma patients.
Area of Science:
- Ophthalmology
- Genetics
- Oncology
Background:
- Retinoblastoma research has yielded significant cancer genetics discoveries but limited clinical treatment advances.
- A key barrier has been the absence of preclinical models accurately reflecting human retinoblastoma's genetic and histopathologic features.
Purpose of the Study:
- To highlight the recent development and characterization of novel animal models for retinoblastoma.
- To emphasize the impact of these models on understanding Rb family gene function and guiding therapeutic strategies.
Main Methods:
- Development and characterization of new animal models for retinoblastoma.
- Utilizing a variety of experimental approaches across multiple laboratories.
- Investigating the consequences of Rb family inactivation in retinal development.
Main Results:
- New animal models now effectively recapitulate the genetic and histopathologic features of human retinoblastoma.
- Broad agreement exists regarding the effects of Rb family inactivation on retinal development.
- These models have facilitated clinical trials and novel therapeutic strategies.
Conclusions:
- Recent advancements in retinoblastoma animal models are critical for translational research.
- These models are instrumental in driving progress toward improved treatments for childhood retinoblastoma.
- Further research using these models promises to accelerate the development of effective therapies.
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...